西诺因通过miR-143-5p减轻尿血病的血管化
Fengyi Yu1,2,3, Zhong Peng2, Ning Gao1
1Department of Nephrology, Yiyang Central Hospital, 118 Kangfubei Road, Yiyang, 413000, Hunan, China.
Scientific reports
|January 13, 2025
概括
通过对miR-143-5p进行上调,Sinomenine有效地降低了大鼠的血管化. 这种微RNA对于预防血管光滑肌肉细胞化至关重要,并且可能在慢性病患者中作为生物标志物.
科学领域:
- 心血管生物学 心血管生物学
- 药理学 药理学是指药理学的学科.
- 分子医学是分子医学.
背景情况:
- 血管化对心血管健康构成重大威胁,由炎症和免疫反应驱动.
- 目前,没有批准的治疗方法可以预防血管化.
- 西诺因表现出已知的抗炎和免疫抑制特性.
研究的目的:
- 调查sinomenine在缓解血管化的有效性.
- 阐明潜在的分子机制,特别关注微RNA调节.
主要方法:
- 使用了氨酸诱导的尿性大鼠模型和血管光滑肌肉细胞 (VSMC) 培养物.
- 使用组织学染色 (Alizarin Red,von Kossa),量化和微型CT进行了血管化评估.
- 使用miRNA测序,生物信息分析和qRT-PCR来识别和验证关键的microRNA.
主要成果:
- 在尿性大鼠中,西诺因 (40 mg/kg/d) 剂量显著降低了大动脉化.
- 在大动脉和VSMC中,sinomenine调高了rno-miR-143-5p的表达,抑制了VSMC化.
- 在慢性病患者和血管化患者中观察到较低的循环miR-143-5p水平.
结论:
- 通过部分调节miR-143-5p,Sinomenine有效地减轻了血管化.
- miR-143-5p对VSMC化起着保护作用,是CKD血管化的潜在生物标志物.
- 西诺因代表了血管化的一种有前途的治疗药物,需要进一步研究.
更多相关视频
08:43Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation
Published on: May 31, 2016
19.5K
07:15Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
343
相关概念视频
MicroRNAs
21.2K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
21.2K
Hormonal Regulation
32.9K
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
32.9K
Antihypertensive Drugs: Vasodilators
473
Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
473
